RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma.
Chan LK, Ho DW, Kam CS, Chiu EY, Lo IL, Yau DT, Cheung ET, Tang CN, Tang VW, Lee TK, Wong CC, Chok KS, Chan AC, Cheung TT, Wong CM, Ng IO.
Chan LK, et al. Among authors: cheung tt, cheung et.
J Hepatol. 2021 Feb;74(2):360-371. doi: 10.1016/j.jhep.2020.08.036. Epub 2020 Sep 9.
J Hepatol. 2021.
PMID: 32918955